STAAR Surgical logo

STAAR Surgical

STAA | NASDAQ
Chart Builder DCF Calculator
$26.01
-$0.38 (-1.44%)
At close: Nov 16, 2026, 4:00 PM ET
$26.01
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-1.44%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
40.6
Fundamentals Average
Market Sentiment Bullish
Moat Narrow
Sector Rank #511/1021 (Top 50%)

Key Statistics

Market Data

Market Cap $1.31B
1D Range
25.82 26.44
52W Range
16.10 33.34

Valuation (TTM)

PE 2.6K
PB 3.47
EV/EBITDA 66.56

Valuation (NTM)

Forward PE 1,319.50
Forward PEG 1.84
Price Target $32.00
Loading financial charts...

Profile

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for visi...

Sector Healthcare
Employees 921
IPO Date Feb 24, 1992
Fiscal Year January - December

Latest News

What STAAR Surgical (STAA) Said on Its Q3 Earnings Call

12 days ago · marketbeat.com

What STAAR Surgical (STAA) Said on Its Q3 Earnings Call
STAAR Surgical Company (STAA) Q3 2026 Earnings Call Transcript

12 days ago · seekingalpha.com

STAAR Surgical Company (STAA) Q3 2026 Earnings Call Transcript
Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates

12 days ago · zacks.com

Staar Surgical (STAA) Surpasses Q3 Earnings and Revenue Estimates
STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific

19 days ago · businesswire.com

STAAR Surgical Appoints Pascal Aeschlimann as Vice President of Asia Pacific
Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline

20 days ago · zacks.com

Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
STAAR Surgical Names Andrew Pilon as Vice President of Business Development

1 month ago · gurufocus.com

STAAR Surgical Names Andrew Pilon as Vice President of Business Development

2 months ago · fool.com

Why Staar Surgical Zoomed Almost 8% Higher on Tuesday
This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

2 months ago · benzinga.com

This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

2 months ago · fool.com

Why Staar Surgical Stock Soared Today
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer

2 months ago · businesswire.com

STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer

Earnings

Latest Earnings
Nov 4, 2026
EPS
$0.11
Beat +116.75%
REV
$83.41M
Beat +5.94%
Next Earnings
Mar 2, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
8
Consensus
Hold
Price Target
$32.00
Upside
+23.03%
Buy (4)
Hold (3)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.